evaluating efficacy of combination therapy with microdermabration and topical Bimatoprost in comparison with topical Bimatoprost alone in vitiligo

Phase 2

Recruiting

• Conditions: vitiligo.; Vitiligo

• Registration Number: IRCT20220129053866N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

patients with vitiligo with age

Exclusion Criteria

segmental vitiligo
received treatment in 3 past months
pregnancy
lactation
hypertension history
asthma history
allergy to drug components

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Repigmentation type. Timepoint: at base line and 1,2,3 and 6 months later. Method of measurement: physical exam.;Repigmentation percentage. Timepoint: at base line and 1,2,3 and 6 months later. Method of measurement: physical exam.

Secondary Outcome Measures

Name	Time	Method
Pruritis. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.;Scaling. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.;Erythema. Timepoint: at base line visit and 1,2,3 and 6 months later. Method of measurement: physical exam and classification of severity to mild, moderate ,severe.